
Ajmera Pharmaceuticals Pvt Ltd
Manufacturer and supplier of herbal and ayurvedic products with diverse therapeutic range.
Manufacturer and supplier of herbal and ayurvedic products with diverse therapeutic range.
Ajmera Pharmaceuticals Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 June 1992 and has a history of 32 years and ten months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹1.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amar Ajmera and Paresh Ajmera serve as directors at the Company.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
U24232MP1992PTC007165
007165
Private Limited Indian Non-Government Company
18 Jun 1992
30 Sep 2024
31 Mar 2024
Unlisted
Roc Gwalior
Ajmera Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pharmaceutical Capsules, Energy Capsules, Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic Medicine, Herbal Platelet Capsule & Tablet, Ayurvedic Immunity Booster, Kadha, Ayurvedic Fever Tablet, Herbal Skin Care Cosmetics.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amar Ajmera ![]() | Director | 01-May-2006 | Current |
Paresh Ajmera ![]() | Director | 01-Sep-2001 | Current |
Ajmera Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 14.17% increase. The company also saw a slight improvement in profitability, with a 9.73% increase in profit. The company's net worth observed a substantial decline by a decrease of 359.17%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Ajmera Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹4.50 M
₹12.10 M
Date | Lender | Amount | Status |
---|---|---|---|
25 Jun 2013 | Hdfc Bank Limited | ₹4.50 M | Open |
14 Mar 2012 | Madhya Pradesh Financial Corporation | ₹2.00 M | Satisfied |
22 Aug 2009 | Madhya Pradesh Financial Corporation | ₹5.00 M | Satisfied |
01 Feb 1999 | State Bank Of Indore | ₹0.50 M | Satisfied |
29 Sep 1998 | State Bank Of Indore | ₹1.70 M | Satisfied |
Ajmera Pharmaceuticals has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ajmera Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajmera Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ajmera Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ajmera Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
A charge with Hdfc Bank Limited of Rs. 4.50 M registered on 25 Jun 2013 with Charge ID 10434147 was modified on 12 Oct 2022.
A charge registered on 14 Mar 2012 via Charge ID 10342122 with Madhya Pradesh Financial Corporation was fully satisfied on 22 Jul 2013.
A charge registered on 22 Aug 2009 via Charge ID 10172905 with Madhya Pradesh Financial Corporation was fully satisfied on 22 Jul 2013.
A charge with Hdfc Bank Limited amounted to Rs. 4.50 M with Charge ID 10434147 was registered on 25 Jun 2013.
Ajmera Pharmaceuticals Pvt Ltd was incorporated on 18 Jun 1992.
The authorized share capital of Ajmera Pharmaceuticals Pvt Ltd is ₹ 2.00 M and paid-up capital is ₹ 2.00 M.
Currently 2 directors are associated with Ajmera Pharmaceuticals Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Ajmera Pharmaceuticals Pvt Ltd is B-9 A Industrial Estate Pologround, India, Indore M.P., Madhya Pradesh, 452015.
The corporate identification number (CIN) of Ajmera Pharmaceuticals Pvt Ltd is U24232MP1992PTC007165 and the company number is 007165 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Ajmera Pharmaceuticals Pvt Ltd has risen by 14.17%.
As Per 2022 financial reports, 32 employees are currently employed by Ajmera Pharmaceuticals Pvt Ltd.
The financial reports for the fiscal year 2022 indicates that The net worth of Ajmera Pharmaceuticals Pvt Ltd has experienced an downturn of -359.17%.
As per the financial statements for fiscal Year 2022, The total open charges for Ajmera Pharmaceuticals Pvt Ltd amount to ₹ 4.50 M.
The most recent Balance Sheet for Ajmera Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
RA
SA
RA
MA